G-CSF and its receptor in myeloid malignancy.

Abstract excerpt

Granulocyte colony-stimulating factor (G-CSF) has been used in the clinic for more than 2 decades to treat congenital and acquired neutropenias and to reduce febrile neutropenia before or during courses of intensive cytoreductive therapy. In addition, healthy stem cell donors receive short-term treatment with G-CSF for mobilization of hematopoietic stem cells. G-CSF has also been applied in priming strategies...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Myelodysplastic Syndromes
• Share to Neoplastic Stem Cells
• Share to Neutropenia